Using a hypercholesterolemic rabbit model, we have previously demonstrated that CAV-1, in association with HDL-C, can be used not only to prevent but also to treat atherosclerosis through the cholesterol efflux pathway, subsequently palliating adverse hepatic reactions in hypercholesterolemic rabbits [25–27]. Here, CAV1 is linked to atherosclerosis.